Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645)

K-Number: K252277 · 2025-10-20

ApplicantVascular Flow Technologies Limited
Decision Date2025-10-20
Product CodeDSY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645) is the device name listed in this FDA 510(k) record. The listed applicant is Vascular Flow Technologies Limited. It received FDA 510(k) clearance on 2025-10-20 under 510(k) number K252277. The device is classified under product code DSY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645)?

Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645) is a medical device that received FDA 510(k) clearance on 2025-10-20. The listed applicant is Vascular Flow Technologies Limited. The 510(k) number is K252277.

When did Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645) receive FDA 510(k) clearance?

Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645) received FDA 510(k) clearance on 2025-10-20, under 510(k) number K252277.

Who is the listed applicant for Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645)?

The FDA 510(k) record lists Vascular Flow Technologies Limited as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645)?

The FDA product code for Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645) is DSY.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT04646226The Arteriovenous Vascular (AV) ACCESS TrialACTIVE_NOT_RECRUITINGNCT07548151Guided Needle Insertion for Vascular AccessCOMPLETEDNCT07773051LineMatrix® Biological Vascular Graft for the Creation of Arteriovenous GraftRECRUITING

Related Devices (Code: DSY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K252445Fusion Bioline Vascular GraftMaquet Cardiovascular, LLCK241550Gelweave™ Vascular ProsthesesVascutek, Ltd.K241070Gelsoft™ Plus Vascular ProsthesesVascutek, Ltd.K231972Advanta VXT Vascular Graft, Flixene Vascular GraftAtrium Medical CorporationK240083GORE® PROPATEN® Vascular GraftW. L. Gore & Associates, Inc.K233783exGraft ePTFE Vascular Grafts, exGraft Carbon ePTFE Vascular GraftsPeca Labs, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑